VANCOUVER, British Columbia--(BUSINESS WIRE)--Mednow Inc. (“Mednow” or the “Company”)(TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company has filed an application for a pharmacy license with the Nova Scotia College of Pharmacists through a wholly-owned subsidiary, Mednow Pharmacy NS Ltd. Upon successful application, this wholly-owned entity will be a licensed pharmacy that will be regulated by Nova Scotia College of Pharmacists as well as provincial and federal regulatory bodies with oversight of pharmacy practices.
Mednow has also secured a lease for a fulfillment center located in Dartmouth, Nova Scotia, located adjacent to the Nova Scotia Health Care System. The Company expects its Nova Scotia fulfillment centre to be operational in the third calendar quarter of 2021 and has appointed Adam Somers as Director of Pharmacy Operations for Nova Scotia. Mr. Somers has over 15 years’ experience in pharmacy operations.
“Mednow is squarely focused on establishing its national platform. Our operations in Ontario and British Columbia are gaining momentum, and now we expect to add both Manitoba and Nova Scotia in the third quarter of 2021. We are considering many options to establish our presence in Alberta and Quebec, while also investing in our digital and logistical infrastructure as we seek to change the way healthcare is delivered in Canada,” said Karim Nassar, CEO of Mednow.
About Mednow Inc.
Mednow is a healthcare technology company offering virtual access with exceptional care. Designed with access and quality care in mind, Mednow.ca provides virtual pharmacy services with convenience and through an interdisciplinary approach to healthcare that is focused on the patient experience. Pharmacy services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmart™ system that packages prescriptions and vitamins by date and time, as well as access to telemedicine.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the timing of operations beginning in Manitoba and Nova Scotia, receipt of all required regulatory approvals from the Manitoba College of Pharmacists, the Nova Scotia College of Pharmacists and other regulatory bodies with oversight of pharmacy practices, the ability to service clients from the Manitoba and Nova Scotia fulfillment centres, the establishment of a presence in Quebec and Ontario, and the benefits and results arising from a national presence. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by management of the Company and the opinions and estimates of management of the Company as of the date of this press release, including that the transactions contemplated herein will close on the terms and timeline as anticipated by the management of the Company. Although the Company considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the transactions contemplated herein will not close on the terms and timeline as anticipated by the management of the Company, or at all, the risk that the Company will not receive required regulatory approvals, the risk that the Company will be unable to complete its proposed activities or realize the benefits or results therefrom, and the other risks and uncertainties applicable to the Company and the business of the Company as set forth in the Company’s final long form prospectus dated February 26, 2021 and its other disclosure available under the Company’s profile at www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations. We seek safe harbor.